Skip to main content
. 2019 May 31;13(5):e0007271. doi: 10.1371/journal.pntd.0007271

Table 2. Summary of findings of the review of immunochromatographic RDTs for the diagnosis of chronic CD in at risk populations.

Interpretative criteria: Endemicity / Stat-Pak Effect (95% CI) # of studies Mean Prevalencea (95% CI) What do these results mean?
All areas Sensitivity: 96.60% (91.3–98.7);
Specificity: 99.27% (98.4–99.7)
12 30.33% (18.6 to 42.0) Of the 30 out of 100 patients with CD, 1 will be missed by a single RDT (3.40% of 30). Of the other 67, not even 1 will have a false positive result of the RDT.
Endemic areas Sensitivity: 98.07% (91.6–99.6);
Specificity: 99.30% (98.3–99.7)
8 35.93% (20.7 to 51.1) Of the 36 out of 100 patients with CD, not even 1 will be missed by a single RDT (1.93% of 33). Of the other 64, not even 1 will have a false positive result of the RDT.
Non-Endemic areas Sensitivity: 89.77% (79.7–95.1);
Specificity: 98.52% (95.0–99.5)
4 19.14% (4.3 to 42.6) Of the 19 out of 100 patients with CD, 2 will be missed by a single RDT (10.23% of 19). Of the other 81, 1 will have a false positive result of the RDT.
Stat-Pak tests only Sensitivity: 97.02% (87.6–99.3);
Specificity: 99.44% (98.6–99.8)
4 26.37% (2.9 to 49.8) Of the 26 out of 100 patients with CD, not even 1 will be missed by a single Stat-Pak test (2.98% of 26). Of the other 74, not even 1 will have a false positive result of the Stat-Pak test.

a Estimates of true prevalences for each study were calculated as described by Rogan and Gladen (1978) [ref.]. CI: confidence interval; RDT: Rapid Diagnostic Test; CD: Chagas disease.